How Immutep Limited stacks up

IMMP · against 22 other Healthcare companies of similar size

Overall

47/ 100

Near the top of its peers.

Ranked #6 of 23 · scores higher than 77% of peers

Bars: peers in each 10-point band of the overall score

6 peers with an overall score of 40–49, including IMMP · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#4 of 22Score 33 / 100 · beats 67%Growth#6 of 20Score 68 / 100 · beats 74%Profitability#20 of 24Score 4 / 100 · beats 17%Risk#4 of 28Lower relative risk · safety 81 · beats 89%

Ranking by overall score

Top 5 and the companies ranked around IMMP

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Austar Lifesciences Limited6118.HK · Hong Kong	272M HKD (≈$35M)	59	97	62	42	1 / 2
2	CellSource Co., Ltd.4880.T · Japan	5.6B JPY (≈$38M)	55	88	10	68	/ 2
3	Transgenic Group Inc.2342.T · Japan	3.5B JPY (≈$24M)	48	65	39	49	1 / 2
3	Intervacc AB (publ)IVACC.ST · Europe	298M SEK (≈$30M)	48	8	94	8	0 / 2
3	Q-linea AB (publ)QLINEA.ST · Europe	276M SEK (≈$28M)	48	0	93	3	0 / 2
6	Immutep LimitedIMMP · US-listed	22M USD	47	33	68	4	0 / 2
7	BioInvent International AB (publ)BINV.ST · Europe	250M SEK (≈$25M)	44	8	92	10	1 / 2
8	Xbrane Biopharma AB (publ)XBRANE.ST · Europe	271M SEK (≈$27M)	41	0	81	26	1 / 2
9	Optimi Health Corp.OPTH · US-listed	12M USD	38	30	92	5	2 / 2
10	Novacyt S.A.NCYT.L · United Kingdom	25M GBP (≈$33M)	31		30	19	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…